Alteration in cellular metabolism is a well-known hallmark of glioblastoma, which is driven by mutations in the genes such as the receptor tyrosine kinase (RTK) and isocitrate dehydrogenase (IDH) pathways [32, 33]. The gene discussed is IDH3A; the disease is glioblastoma.